Table of Contents Author Guidelines Submit a Manuscript
Multiple Sclerosis International
Volume 2013 (2013), Article ID 972471, 8 pages
Review Article

The Gap in the Current Research on the Link between Health Locus of Control and Multiple Sclerosis: Lessons and Insights from a Systematic Review

School of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Via Pastore 1, 16132 Genoa, Italy

Received 9 November 2012; Revised 13 January 2013; Accepted 14 January 2013

Academic Editor: W. Bruck

Copyright © 2013 Nicola Luigi Bragazzi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Multiple sclerosis (MS) is a chronic neurological disease whose etiology has not been fully understood yet in detail. Empirical findings show how psychosocial symptoms are very important features of the clinical presentation of MS, having a deep impact on patient's quality of life, and thus psychological coping strategies may play a central role in reducing the burden of the disease and improving patient's satisfaction of life. MS progression and relapses/exacerbations are unpredictable and may depend on factors such as stressor chronicity, frequency, severity, type, and individual patient characteristics such as depression, personality, locus of control (LOC), optimism, and perceived social support. Due to its importance for health-care delivery, rehabilitation, and nursing, here, we make a systematic review on the current state-of-the-art studies concerning the relationship between LOC and MS, according to the PRISMA guidelines, and we assess the quality and the completeness of the studies using the CONSORT instrument, underpinning their limitations, and suggesting how to fill the gap in this research field.

1. Introduction

1.1. Multiple Sclerosis

Multiple sclerosis (MS) is a chronic autoimmune inflammatory progressive neurological disorder resulting in injury of the oligodendrocytes and in axonal demyelination [1]. There are at least 2–2.5 million patients worldwide suffering from MS, and its prevalence is unevenly distributed and highly variable from less than 5 cases per 100,000 inhabitants up to more than 100–200 cases per 100,000 inhabitants [2]. It is more likely to affect women than men with a ratio of 2.3 which has gradually increased over time, and the age of onset is generally young adulthood, usually affecting people in their 20s or 30s [3], even though pediatric and late onset as well as clinical variants have been reported.

The progress of the disease is extremely variable and unpredictable, the etiology is unclear, there is currently no cure, and only symptomatic therapy is available [1].

1.2. The Psychosocial Burden

Psychosocial symptoms are very important clinical features of the presentation of MS, having a deep impact on patient’s quality of life [4], thus suggesting an integrated biopsychosocial approach [5, 6] to the disease, as also strongly recommended by the American MS task force [7]. Psychological symptoms include above all depression [8], with a rather high prevalence around 50%, as reported by the recent large-scale study of anxiety and depression prevalence in people with MS in the UK [9]. Depression is more common during relapses and seems to exacerbate other symptoms such as fatigue and cognitive dysfunction [9]. Anxiety, as well as perceived stress and psychological distress, is also frequent while other psychiatric illnesses occur less frequently in MS [1013].

MS, being a chronic disease, has a deep impact on patient’s life since it can impair patient’s life goals, such as employment, income, and living daily activities as well as social relationships and interactions. Collected evidence indicates that the relationship between life stress and relapse is complex and is likely to depend on factors, such as stressor chronicity, frequency, severity, and type, and individual patient characteristics, such as depression, health locus of control (LOC), optimism [14], self-efficacy [15], spirituality [16], perceived social support [17], and coping strategy use [18]. Moreover, a quarter of MS patients suffer from suicidal ideation [19, 20], being the risk of suicide 5–10 higher than in the general population [19].

For these reasons, psychological symptoms in MS patients should not be underestimated and should be properly addressed by the clinicians, since an earlier diagnosis of these disorders could ameliorate patient’s quality of life and MS course. Thus, studying the psychosocial burden of MS has a great pragmatical value and can help in designing an ad hoc psychosocial intervention.

Due to its importance for health-care delivery, rehabilitation, and nursing, here, we make a systematic review on the current state of art concerning the relationship between LOC and MS.

1.3. Health Locus of Control

LOC is the patient’s belief in the location of the control over results of his/her behavior [2023], that is to say a method or a strategy that patients use in order to attribute the cause of their own disease. An individual who thinks that he/she can determine events in his/her environment by his/her own actions is said to have an internally oriented LOC. The contrary orientation is referred as externality of LOC [24]. Internal LOC in fact correlates with volitional perception, an idea of a controllable (and curable) disease, while external LOC reflects the patient's impression of an incurable illness and a denial of its symptoms, which often leads to refusing care and rehabilitation [24].

LOC could be linked to stress, whose correlation with MS has been extensively investigated, in particular from a psychoneuroimmunological perspective. Stressful events can lead to an activation of endocrine (hypothalamus-pituitary-adrenal axis) and autonomic pathways, as well as to a dysregulation of immune system, thus influencing the relapse and the course of MS [25]. Even though a psychobiological explanation of LOC is lacking, there are some empirical studies that have shown a correlation between salivary immunoglobulin A (IgA) and LOC orientation [26], while other researchers have found internal LOC working as a “buffer” against the decrease of cellular immunity in depression (the so-called “immune control theory”) [27].

LOC has a profound impact on patient’s behaviors, such as increased motivation in seeking health-related information, compliance, and adherence to the treatment, that are of fundamental importance in order to properly manage MS course. Thus, the understanding of LOC would help physicians to better treat MS patients, since psychological parameters could be modified through a psychotherapeutic intervention, while physical symptoms are more persistent and refractory to being adjusted.

2. Materials and Methods

This systematic review was carried out according to the standards of Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines [28], and the study protocol was registered in PROSPERO database (registration number: CRD42013003586, date of approved registration: January 8th 2013). MEDLINE/PubMed, PsycINFO, and ISI Web of Knowledge archives and databases were consulted and scanned, searching for a combination of keywords, namely “multiple sclerosis” and “health locus of control,” using Medical Subject Headings (MeSH) terms as vocabulary, according to the NCBI nomenclature and guidelines.

Inclusion criteria were (1) articles fully peer-reviewed, (2) articles with relevant quantitative details and information about the type of study (randomized clinical trial, matched case-control, cohort study, and so on), (3) clearly stated collected evidence and results, and (4) articles being written in English language.

Exclusion criteria were (1) conference proceedings and other not fully peer-reviewed material, (2) items not directly pertinent to the query string, (3) articles not containing sufficient information, and (4) articles not written in English language, which consequently were discarded.

The collected articles were rigorously assessed using the Consolidated Standards of Reporting Trials (CONSORT) instrument, developed by Turner et al. [29] and summarized in Table 1.

Table 1: Grid used for assessing the papers (adapted from Moher).

3. Results

Our initial query resulted in 47 hits (specifically, 18 articles from MEDLINE/PubMed, 2 from PsycINFO, and 27 from ISI Web of Knowledge), and after discarding the duplicated items the resulting list included 28 nonredundant articles. Only 9 studies were finally considered in our systematic review (3 articles were discarded being a review, 1 not being a fully peer-reviewed manuscript but a conference proceeding, 8 not being directly pertinent to MS, 4 not being written in English language, 1 not being sufficiently quantitative, 1 not being directly pertinent to the relationship between LOC and MS, but focusing on therapy, and 1 for sampling issues). The final list of selected articles is summarized in Table 2.

Table 2: All articles collected for the systematic review.

4. Discussion

Studying a randomly selected sample of 157 subjects, Garfield and Lincoln [30] interestingly found a rather high prevalence of anxiety among MS patients (about 56.7%), which correlated with gender, self-efficacy, depression, self-perceived stress, and disability. Years since diagnosis, months since the last relapse, and age were instead not statistically significant in correlation with anxiety. LOC was not found to be a significantly correlated variable.

Using the Weiner’s causal attribution and control cognitions perceptual framework, Wells et al. [31] failed to find a connection between LOC and fatigue/pain perception. In a sample of 140 participants, fatigue threshold was correlated with causal attributions, control cognitions, and exercise frequency, but not with LOC.

Gay et al. [32] used the causal pathway analysis (developed by Sewell Right) to model the data obtained from assessing a sample of 115 patients and found that LOC could not be used to predict patient's psychological attitudes.

Vuger-Kovačić et al. [33] found that most MS patients exhibited external LOC and showed a correlation between LOC orientation and time since MS diagnosis as well as depression.

Using Smith’s quality of life conceptual framework based on four components (namely, clinical health, role performance, adaptability, and wellbeing), Schwartz [34] investigated a pool of 136 randomly selected MS patients and repeated the measurements after 2, 12, 18, and 24 months. Schwartz compared two different kinds of psychological interventions: one being a coping skills teaching group, the other being a peer telephone support intervention, as offered by the National MS Society. The two groups differed in many aspects, such as in the degree of professionalism, commitment, and efforts, in the involvement of lay resources and people, and in how directive they were. The author found that the peer support intervention increased the externality of LOC but did not influence psychosocial role performance or wellbeing.

L. Macleod and G. Macleod [35] investigated a very small MS sample (20 subjects) and did not find any correlation between internality of LOC and clinical and psychological variables.

Wassem [36] studied 100 randomly selected MS patients from a MS support group and found that LOC was a good predictor of patient’s strategies, coping, level of knowledge, and level of self-care practices. Interestingly, LOC was not statistically correlated with time since the diagnosis.

Investigating a population of 60 MS patients, Halligan and Reznikoff [37] found that internal LOC was negatively correlated with depression and positively with body image and perception but was uncorrelated with disease duration or disability.

Brooks and Matson [38] investigated 103 MS patients and found that females were more likely to show positive adjustment. Subjects with an internal LOC had more positive adjustment scores.

5. Conclusion

Despite the increasing body of research devoted to the psychological aspects of MS, the relationship between the disease and LOC has been poorly explored.

Our research resulted in only 9 fully peer-reviewed studies, which however presented a different range of quality and academic rigor and some limitations. Only 1 study explicitly used a rigorous method (namely, the Dillman’s total design method), including sample size effect calculation and properly estimating the minimum number of participants required to detect a significant difference among compared groups. Only 1 study reported the highest score possible using Moher’s CONSORT assessment instrument. In the other studies the quality was rather poor. Most studies used self-reported questionnaires, without an external validation of a psychologist or a psychiatrist. This could also lead to a bias, excluding patients not able to compile questionnaires, such as those suffering from cognitive impairment. Thus, the generalization of these studies to larger samples and populations is questionable. Moreover, only in few studies the self-report scales concerning MS disabilities were confirmed by a neurologist or supported by clinical findings and neuroimaging.

Apart from the researches carried out by Schwartz [34] and by Brooks and Matson [38], which represent a longitudinal trial, all the other researches are cross-sectional, and studies of this kind are of difficult interpretation because it is hard to understand whether anxiety, depression, or other psychological strategies are a consequence of the disease (causal inference) or rather a reaction to the illness.

Few studies are theory-driven and use a well-established conceptual framework, such as those by Wells et al. [31] and by Schwartz [34].

Other concerns are quite technical and are the following: the limited dimension of the samples (with the exception of the study by Vuger-Kovačić et al. [33], which included more than 400 patients, the other study sample size was less than 200, in the range 20–157), the possibility of incurring in type 1 error due to multiple analysis, the psychometric parameters of the used scales (such as in some cases the low consistency rate and the Cronbach’s alpha coefficient). The control group was well established only in few studies, such as those by Brooks and Matson [38], which used an external control group of healthy subjects, with similar age and gender distribution.

On the basis of the evidences we collected we can conclude as follows.(1)Externality of LOC is a predictor of higher disabilities, depression, anxiety, and stress level; only three studies seem to contradict this conclusion, namely, the study by Garfield and Lincoln [30], the one by Gay et al. [32], and the study by L. Macleod and G. Macleod [35].(2)There seems to be a link between externality of LOC and self-reported symptoms as fatigue, as noted by Wells et al., 2012 [31].(3)Internality of LOC and good and positive representations of the disease are predictors of the patient’s behaviors and attitudes, such as compliance and adherence to therapy and to social support request/access. Moreover internality of LOC is generally present in subjects with higher knowledge and self-awareness of their disease, who result to be more informed, practicing more self-care than those with an external LOC.(4)An interesting study by Brooks and Matson [38] suggests that LOC may be linked to gender, since they found that females were more likely to have an internal LOC than males.(5)There are very few studies focusing on the changes of LOC during the progression of MS; an important exception is the beautiful study carried out by Vuger-Kovačić et al. [33], who demonstrated a shift of LOC, which has not been found instead by Halligan and Reznikoff et al. [37] and by Wassem [36].(6)Another little studied topic is the relationship between LOC and the type of psychological support adopted by the physicians. Practitioners should be aware that the methodology of psychological help can have an important influence on the externality of LOC, as shown by Schwartz [34]. In this study teaching how to enhance adaptive attitudes and coping skills (addressing emotional impairment, difficulties in mood, cognitive deficits, and communications with the caregivers) resulted in a better health outcome, while less favorable results were obtained with the help of peer telephone support groups based on Rogerian client-centered psychotherapy. The former intervention exploited trained professionals, required a high degree of commitment and efforts, being highly directive and bilateral, and the latter made use of lay people and resources and was not directive. However from a subgroup analysis, it emerged that the peer support group was more helpful for MS patients suffering from depression or other affective problems than the other psychological intervention. Other studies have shown that supportive psychotherapy, modulating and enhancing patient’s self-efficacy, can result in a better health outcome and self-reported quality of life, as shown by Riazi et al. [39]. Combined pharmacological treatment and psychological/social/occupational support are referred to as multidisciplinary intervention (MI). Research in other areas has offered evidence that MI can change and modulate health-related outcomes, including LOC, for example, in the treatment of fibromyalgia [40] or chronic stage of stroke [41], but the effects of MI on MS patients have been poorly investigated, with a lack of evidence [42].Further research will be needed for a better understanding of the role played by LOC in MS patients and for providing a better healthcare service. Future studies should be carried out according to a standardized randomized protocol, recruiting a large sample, defining clearly inclusion/exclusion criteria, establishing control groups, and using a solid conceptual framework [42].


  1. S. L. Hauser and D. S. Goodwin, “Multiple sclerosis and other demyelinating diseases,” in Harrison’s Principles of Internal Medicine, A. S. Fauci, E. Braunwald, D. L. Kasper, and S. L. Hauser, Eds., vol. 2, pp. 2611–2621, McGraw-Hill Medical, New York, NY, USA, 17th edition, 2008. View at Google Scholar
  2. R. Milo and E. Kahana, “Multiple sclerosis: geoepidemiology, genetics and the environment,” Autoimmunity Reviews, vol. 9, no. 5, pp. A387–A394, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Alonso and M. A. Hernán, “Temporal trends in the incidence of multiple sclerosis: a systematic review,” Neurology, vol. 71, no. 2, pp. 129–135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. José Sá, “Psychological aspects of multiple sclerosis,” Clinical Neurology and Neurosurgery, vol. 110, no. 9, pp. 868–877, 2008. View at Publisher · View at Google Scholar
  5. M. Eid, “The bio-psycho-social model: how accurate and valid is it?” Journal of Psychology and Psychotherapy, vol. 2, article e103, 2012. View at Google Scholar
  6. N. L. Bragazzi and G. Del Puente, “The bio-psycho-social model and beyond: its limitations and the need for a new model. A response to eid's editorial ‘the bio-psycho-social model: how accurate and valid is it?’,” Open Access Scientific Reports, vol. 1, no. 8, p. 399, 2012. View at Google Scholar
  7. Goldman Consensus Group, “The Goldman Consensus statement on depression in multiple sclerosis,” Multiple Sclerosis, vol. 11, no. 3, pp. 328–337, 2005. View at Publisher · View at Google Scholar
  8. A. Feinstein, “Multiple sclerosis and depression,” Multiple Sclerosis, vol. 17, no. 11, pp. 1276–1281, 2011. View at Publisher · View at Google Scholar
  9. K. H. Jones, D. V. Ford, P. A. Jones et al., “A large-scale study of anxiety and depression in people with Multiple Sclerosis: a survey via the web portal of the UK MS Register,” PLoS ONE, vol. 7, no. 7, Article ID e41910, 2012. View at Google Scholar
  10. C. I. Mitsonis, C. Potagas, I. Zervas, and K. Sfagos, “The effects of stressful life events on the course of multiple sclerosis: a review,” International Journal of Neuroscience, vol. 119, no. 3, pp. 315–335, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. R. F. Brown, C. C. Tennant, S. M. Dunn, and J. D. Pollard, “A review of stress-relapse interactions in multiple sclerosis: important features and stress-mediating and -moderating variables,” Multiple Sclerosis, vol. 11, no. 4, pp. 477–484, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. K. Artemiadis, A. A. Vervainioti, E. C. Alexopoulos, A. Rombos, M. C. Anagnostouli, and C. Darviri, “Stress management and multiple sclerosis: a randomized controlled trial,” Archives of Clinical Neuropsychology, vol. 27, no. 4, pp. 406–416, 2012. View at Publisher · View at Google Scholar
  13. B. Rapaport and S. Karceski, “Multiple sclerosis and stress,” Neurology, vol. 79, no. 5, pp. e47–e49, 2012. View at Publisher · View at Google Scholar
  14. M. Fournier, D. de Ridder, and J. Bensing, “Optimism and adaptation to chronic disease: the role of optimism in relation to self-care options of type I diabetes mellitus, rheumatoid arthritis and multiple sclerosis,” British Journal of Health Psychology, vol. 7, no. 4, pp. 409–432, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Ng, P. Kennedy, B. Hutchinson et al., “Self-efficacy and health status improve after a wellness program in persons with multiple sclerosis,” Disability and Rehabilitation, 2012. View at Publisher · View at Google Scholar
  16. A. Büssing, P. F. Matthiessen, and T. Ostermann, “Engagement of patients in religious and spiritual practices: confirmatory results with the SpREUK-P 1.1 questionnaire as a tool of quality of life research,” Health and Quality of Life Outcomes, vol. 3, article 53, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Suh, M. Weikert, D. Dlugonski, B. Sandroff, and R. W. Motl, “Physical activity, social support, and depression: possible independent and indirect associations in persons with multiple sclerosis,” Psychology, Health and Medicine, vol. 17, no. 2, pp. 196–206, 2012. View at Google Scholar
  18. M. P. McCabe, M. Stokes, and E. McDonald, “Changes in quality of life and coping among people with multiple sclerosis over a 2 year period,” Psychology, Health and Medicine, vol. 14, no. 1, pp. 86–96, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Feinstein, “An examination of suicidal intent in patients with multiple sclerosis,” Neurology, vol. 59, no. 5, pp. 674–678, 2002. View at Google Scholar · View at Scopus
  20. M. Pompili, A. Forte, M. Palermo et al., “Suicide risk in multiple sclerosis: a systematic review of current literature,” Journal of Psychosomatic Research, vol. 73, no. 6, pp. 411–417, 2012. View at Publisher · View at Google Scholar
  21. P. Theofilou and A. R. Saborit, “Health locus of control and diabetes adherence,” Journal of Psychology and Psychotherapy, vol. 3, p. e002, 2012. View at Google Scholar
  22. P. Theofilou, “Interventions to support medication adherence in individuals with chronic disease: the role of health professionals,” Journal of Community Medicine and Health Education, vol. 2, article e104, 2012. View at Google Scholar
  23. P. Theofilou, “Factors affecting level of compliance in chronic patients,” Internal Medicine, vol. 2, p. e106, 2012. View at Google Scholar
  24. M. A. Rowe, “The impact of internal and external resources on functional outcomes in chronic illness,” Research in Nursing and Health, vol. 19, no. 6, pp. 485–497, 1996. View at Google Scholar · View at Scopus
  25. S. Kern and T. Ziemssen, “Brain-immune communication psychoneuroimmunology of multiple sclerosis,” Multiple Sclerosis, vol. 14, no. 1, pp. 6–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. K. A. Kubitz, B. S. Peavey, and B. S. Moore, “The effect of daily hassles of humoral immunity: an interaction moderated by locus of control,” Biofeedback and Self-Regulation, vol. 11, no. 2, pp. 115–123, 1986. View at Google Scholar · View at Scopus
  27. C. Reynaert, P. Janne, A. Bosly et al., “From health locus of control to immune control: internal locus of control has a buffering effect on natural killer cell activity decrease in major depression,” Acta Psychiatrica Scandinavica, vol. 92, no. 4, pp. 294–300, 1995. View at Google Scholar · View at Scopus
  28. D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, and The PRISMA Group, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” PLoS Medicine, vol. 6, no. 6, Article ID e1000097, 2009. View at Google Scholar
  29. L. Turner, L. Shamseer, D. G. Altman et al., “Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals,” Cochrane Database of Systematic Reviews, vol. 11, Article ID MR000030, 2012. View at Publisher · View at Google Scholar
  30. A. C. Garfield and N. B. Lincoln, “Factors affecting anxiety in multiple sclerosis,” Disability and Rehabilitation, vol. 34, no. 24, pp. 2047–2052, 2012. View at Publisher · View at Google Scholar
  31. L. Wells, E. B. Thorsteinsson, and R. F. Brown, “Control cognitions and causal attributions as predictors of fatigue severity in a community sample,” Journal of Social Psychology, vol. 152, no. 2, pp. 185–198, 2012. View at Publisher · View at Google Scholar
  32. M. C. Gay, P. Vrignaud, C. Garitte, and C. Meunier, “Predictors of depression in multiple sclerosis patients,” Acta Neurologica Scandinavica, vol. 121, no. 3, pp. 161–170, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Vuger-Kovačić, R. Gregurek, D. Kovačić, T. Vuger, and B. Kalenić, “Relation between anxiety, depression and locus of control of patients with multiple sclerosis,” Multiple Sclerosis, vol. 13, no. 8, pp. 1065–1067, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. C. E. Schwartz, “Teaching coping skills enhances quality of life more than peer support: results of a randomized trial with multiple sclerosis patients,” Health Psychology, vol. 18, no. 3, pp. 211–220, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. L. MacLeod and G. MacLeod, “Control cognitions and psychological disturbance in people with contrasting physically disabling conditions,” Disability and Rehabilitation, vol. 20, no. 12, pp. 448–456, 1998. View at Google Scholar · View at Scopus
  36. R. Wassem, “A test of the relationship between health locus of control and the course of multiple sclerosis,” Rehabilitation Nursing, vol. 16, no. 4, pp. 189–193, 1991. View at Google Scholar · View at Scopus
  37. F. R. Halligan and M. Reznikoff, “Personality factors and change with multiple sclerosis,” Journal of Consulting and Clinical Psychology, vol. 53, no. 4, pp. 547–548, 1985. View at Publisher · View at Google Scholar · View at Scopus
  38. N. A. Brooks and R. R. Matson, “Social-psychological adjustment to multiple sclerosis. A longitudinal study,” Social Science and Medicine, vol. 16, no. 24, pp. 2129–2135, 1982. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Riazi, A. J. Thompson, and J. C. Hobart, “Self-efficacy predicts self-reported health status in multiple sclerosis,” Multiple Sclerosis, vol. 10, no. 1, pp. 61–66, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. A. de Rooij, L. D. Roorda, R. H. J. Otten, M. van der Leeden, J. Dekker, and M. P. M. Steultjens, “Predictors of multidisciplinary treatment outcome in fibromyalgia: a systematic review,” Disability and Rehabilitation, 2012. View at Publisher · View at Google Scholar
  41. S. Mehta, S. Pereira, S. Janzen, A. McIntyre, A. McClure, and R. W. Teasell, “Effectiveness of psychological interventions in chronic stage of stroke: a systematic review,” Topics in Stroke Rehabilitation, vol. 19, no. 6, pp. 536–544, 2012. View at Publisher · View at Google Scholar
  42. L. K. Storr, P. S. Sørensen, and M. Ravnborg, “The efficacy of multidisciplinary rehabilitation in stable multiple sclerosis patients,” Multiple Sclerosis, vol. 12, no. 2, pp. 235–242, 2006. View at Publisher · View at Google Scholar · View at Scopus